证券代码：600881 证券简称：亚泰集团 公告编号：临 2025-043 号 吉林亚泰（集团）股份有限公司 2025 年度日常关联交易的公告 特 别 提 示 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 重要内容提示： ● 是否需要提交股东大会审议：是 ● 日常关联交易对本公司的影响：2025年度日常关联交易为公司 正常生产经营需要，公司与关联方之间的日常关联交易遵循公允的 价格和条件，不存在损害公司和股东利益的情形，不会对公司独立 性产生影响。 一、日常关联交易的基本情况 （一）日常关联交易履行的审议程序 吉林亚泰（集团）股份有限公司（以下简称"公司"）2025 年 4 月 27 日召开了第十三届第七次董事会、第十三届第七次监事会，审 议通过了《关于公司 2025 年度日常关联交易的议案》，公司董事于 来富先生和监事陈波先生回避表决。 公司独立董事 2025 年第二次专门会议对此议案进行了事前审 1 议，全体独立董事一致同意公司 2025 年度日常关联交易事项，并同 意提交公司董事会审议。 （二）2024年度日常关联交 ...

吉林亚泰（集团）股份有限公司 关于筹划重大资产出售暨关联交易的进展公告 特 别 提 示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 一、本次交易概述 2024 年 3 月 27 日，吉林亚泰（集团）股份有限公司（以下简称 "公司"）分别与长春市城市发展投资控股（集团）有限公司（以下 简称"长发集团"）、长春市金融控股集团有限公司（以下简称"长春 市金控"）签署了《意向协议》，公司拟将持有的东北证券股份有限公 司（以下简称"东北证券"）20.81%股份出售给长发集团，拟将持有 的东北证券 9%股份出售给长春市金控或其指定的下属子公司。 公司本次出售已经构成《上市公司重大资产重组管理办法》规定 的重大资产重组。 公司于 2024 年 3 月 28 日披露了《吉林亚泰（集团）股份有限公 司关于筹划重大资产出售暨关联交易的提示性公告》（公告编号：临 2024-016 号），对本次交易涉及的相关事项进行了详细说明。 公司分别于 2024 年 5 月 9 日、6 月 8 日、7 月 9 日、8 月 9 日、 9 月 10 日、9 月 ...

吉林亚泰（集团）股份有限公司 关于北京德皓国际会计师事务所（特殊普通合伙） 履职情况的评估报告 吉林亚泰（集团）股份有限公司（以下简称"公司"）聘 请北京德皓国际会计师事务所（特殊普通合伙）（以下简称 "北京德皓国际会计师事务所"）作为公司 2024 年度审计机构。 根据财政部、国务院国有资产监督管理委员会、中国证券监 督管理委员会颁布的《国有企业、上市公司选聘会计师事务 所管理办法》，公司对北京德皓国际会计师事务所 2024 年 度审计过程中的履职情况进行评估。经评估，公司认为，北 京德皓国际会计师事务所在资质等方面合规有效，能够保持 独立性，勤勉尽责，客观、公允地出具相关审计报告。具体 情况如下： 一、2024 年年审会计师事务所基本情况 1、基本信息 名称：北京德皓国际会计师事务所（特殊普通合伙） 成立日期：2008 年 12 月 8 日 组织形式：特殊普通合伙 注册地址：北京市西城区阜成门外大街 31 号 5 层 519A 首席合伙人：杨雄 截止 2024 年 12 月 31 日，北京德皓国际会计师事务所 合伙人 66 人，注册会计师 300 人，签署过证券服务业务审 计报告的注册会计师人数 140 ...

证券代码：600881 证券简称：亚泰集团 公告编号：临 2025-039 号 吉林亚泰（集团）股份有限公司 第十三届第七次监事会决议公告 特 别 提 示 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 吉林亚泰（集团）股份有限公司（以下简称"公司"）第十三届第 七次监事会会议于 2025 年 4 月 27 日在亚泰会议中心会议室召开，经 过半数以上监事推举，监事陈波先生主持了会议，会议应出席监事 6 名，实际出席监事 6 名，会议符合法律、法规、规章和《公司章程》 的有关规定，会议审议并一致通过了以下议案： 一、审议通过了公司 2024 年度监事会工作报告。 表决结果：同意 6 票，反对 0 票，弃权 0 票。 二、审议通过了公司 2024 年度利润分配方案。 监事会认为，公司 2024 年度利润分配方案符合相关法律、法规 以及《公司章程》的规定，不存在损害公司及股东利益的情形。同意 公司 2024 年度利润分配方案，同意将该方案提交股东大会审议。 表决结果：同意 6 票，反对 0 票，弃权 0 票。 三、审议通过了公司 ...

吉林亚泰（集团）股份有限公司 监事会对董事会关于公司 2024 年度非标准审计意见 涉及事项的专项说明的意见 北京德皓国际会计师事务所（特殊普通合伙）为吉林亚 泰（集团）股份有限公司（以下简称"公司"）2024 年度财 务报表出具了保留意见的审计报告，为公司 2024 年度内部 控制出具了带强调事项段无保留意见的审计报告。根据中国 证券监督管理委员会《公开发行证券的公司信息披露编报规 则第 14 号——非标准审计意见及其涉及事项的处理》和《上 海证券交易所股票上市规则》的要求，公司监事会认真审阅 了董事会出具的专项说明，并提出如下审核意见： 监事会认为，董事会关于公司 2024 年度非标准审计意 见涉及事项的专项说明符合公司实际情况，同意董事会出具 的专项说明。监事会将持续督促公司董事会和管理层尽快采 取有效措施，努力降低和消除相关事项对公司的不利影响。 吉林亚泰（集团）股份有限公司 监 事 会 二〇二五年四月二十七日 ...

证券代码：600881 证券简称：亚泰集团 公告编号：临 2025-038 号 特 别 提 示 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 吉林亚泰（集团）股份有限公司（以下简称"公司"）第十三届 第七次董事会会议于 2025 年 4 月 27 日在亚泰会议中心会议室举 行，副董事长、总裁刘树森先生主持了会议，会议应出席董事 10 名，实际出席董事 10 名，会议符合法律、法规、规章和《公司章 程》的有关规定，会议审议并一致通过了以下议案： 一、审议通过了公司 2024 年度董事会工作报告。 本报告尚需提交公司股东大会审议。 表决结果：同意 10 票，反对 0 票，弃权 0 票。 吉林亚泰（集团）股份有限公司 第十三届第七次董事会决议公告 二、审议通过了公司 2024 年度独立董事述职报告（分项表 决）。 1.邴正先生 2024 年度独立董事述职报告。 表决结果：同意 10 票，反对 0 票，弃权 0 票。 2.杜婕女士 2024 年度独立董事述职报告。 表决结果：同意 10 票，反对 0 票，弃权 0 票。 1 3.毛 ...

Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,026,176,214.11, representing a 2.55% increase compared to CNY 1,000,650,375.76 in the same period last year[4] - The net profit attributable to shareholders was a loss of CNY 468,952,958.90, an improvement of 9.10% from a loss of CNY 515,915,343.05 in the previous year[4] - The basic and diluted earnings per share were both CNY -0.14, showing a 12.50% improvement from CNY -0.16 in the previous year[4] - The net loss for Q1 2025 was a loss of $591,646,714.10, compared to a loss of $643,559,088.27 in Q1 2024, indicating an improvement of approximately 8.06%[22] - The total comprehensive loss for Q1 2025 was $674,315,424.80, compared to a loss of $637,229,943.20 in Q1 2024[23] Cash Flow and Assets - The net cash flow from operating activities was a negative CNY 315,161,733.63, which is a decline of 11.58% compared to a negative CNY 282,442,386.93 in the same period last year[4] - The company's cash and cash equivalents decreased to approximately 712.60 million RMB from 739.47 million RMB at the end of 2024[15] - The company's current assets totaled approximately 19.06 billion RMB, an increase from 18.89 billion RMB at the end of 2024, driven by an increase in inventory[16] - The total liabilities as of March 31, 2025, were approximately 39.51 billion RMB, compared to 38.88 billion RMB at the end of 2024, indicating a rise in short-term borrowings[17] - Cash and cash equivalents at the end of Q1 2025 were $208,683,001.46, down from $234,186,154.81 at the end of Q1 2024[26] - The company reported a net cash outflow from operating activities of $315,161,733.63 in Q1 2025, compared to an outflow of $282,442,386.93 in Q1 2024[26] Equity and Shareholder Information - The weighted average return on equity decreased to -18.42%, down 9.04 percentage points from -9.38% in the previous year[5] - Shareholders' equity attributable to shareholders decreased by 20.07% to CNY 2,222,667,052.15 from CNY 2,780,761,093.86 at the end of the previous year[5] - The company’s equity attributable to shareholders decreased to approximately 2.22 billion RMB from 2.78 billion RMB at the end of 2024[18] Investments and Subsidiaries - The company completed the transfer of equity in Jiangsu Weikail Medical Technology Co., Ltd., with the necessary registration procedures finalized[11] - A proposal to establish a subsidiary of Jilin Yatai Construction Engineering Co., Ltd. was approved in the fourth executive meeting of the company on January 20, 2025[11] - The company established a joint venture named "Yatai Jinchuan (Dalian) Construction Engineering Co., Ltd." with a registered capital of 10 million RMB, where Jilin Yatai Construction Engineering Co., Ltd. contributed 3 million RMB (30%) and Dalian Jinhui Navigation Co., Ltd. contributed 4.9 million RMB (49%)[12] - The company approved the establishment of a wholly-owned subsidiary, "Jilin Yatai Group Environmental Technology Co., Ltd.," with a registered capital of 20 million RMB, focusing on cement production and sales, among other activities[13] Operating Costs and Expenses - Total operating costs rose to $1,734,625,516.81 in Q1 2025 from $1,700,488,725.15 in Q1 2024, marking an increase of about 2.01%[21] - Research and development expenses increased to $16,532,351.27 in Q1 2025 from $12,238,232.70 in Q1 2024, reflecting a growth of approximately 35.4%[21]

证券代码：600881 证券简称：亚泰集团 公告编号：临 2025-040 号 吉林亚泰（集团）股份有限公司 关于 2024 年度拟不进行利润分配的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 重要内容提示： ●吉林亚泰（集团）股份有限公司（以下简称"公司"）2024 年 度拟不进行利润分配，也不进行资本公积金转增股本。 ●本次利润分配方案已经公司第十三届第七次董事会、第十三届 第七次监事会审议通过，尚需提交公司股东大会审议。 ●公司不触及《上海证券交易所股票上市规则》（以下简称《股 票上市规则》）第 9.8.1 条第一款第（八）项规定的可能被实施其他 风险警示的情形。 一、公司 2024 年度利润分配方案内容 （一）利润分配方案的具体内容 经北京德皓国际会计师事务所（特殊普通合伙）审计，2024 年 母公司实现净利润-2,209,030,378.48 元，加上年初未分配利润 -1,263,393,543.39 元，年末可供分配利润为-3,472,423,921.87 元。 鉴于公司 2024 年度亏损且年末可供股东 ...

Financial Performance - In 2024, the company's operating revenue was CNY 7,214,631,554.39, a decrease of 22.02% compared to CNY 9,251,829,386.34 in 2023[22] - The net profit attributable to shareholders was CNY -2,917,961,096.59, showing an improvement of 26.08% from CNY -3,947,472,700.96 in the previous year[22] - The net cash flow from operating activities decreased by 78.32% to CNY 551,177,967.30, down from CNY 2,541,829,855.72 in 2023[22] - The total assets at the end of 2024 were CNY 42,239,691,474.42, a decline of 7.29% from CNY 45,561,023,913.73 in 2023[22] - The net assets attributable to shareholders decreased by 51.71% to CNY 2,780,761,093.86, compared to CNY 5,758,572,332.47 in 2023[22] - The basic earnings per share for 2024 was CNY -0.90, an improvement of 26.23% from CNY -1.22 in 2023[23] - The weighted average return on equity was -67.87%, a decrease of 16.44 percentage points from -51.43% in 2023[23] - The company reported a negative distributable profit of CNY -3,472,423,921.87 at the end of 2024, leading to no profit distribution or capital reserve transfer[4] Sector Performance - The construction materials sector faced a significant decline in demand, with a focus on developing local cement markets and strategic partnerships[32] - The pharmaceutical sector saw a 20% year-on-year increase in online sales revenue, driven by enhanced channel development[33] - The construction materials sector generated revenue of CNY 3,246,234,788.05, with a gross margin of 10.68%, down 10.12% year-on-year[45] - The real estate sector reported revenue of CNY 779,662,871.30, with a gross margin of 17.49%, a decrease of 5.89 percentage points compared to the previous year[45] - The pharmaceutical sector's revenue was CNY 1,796,297,670.37, maintaining a gross margin of 43.00%, down 3.72 percentage points year-on-year[45] Operational Adjustments - The company plans to streamline operations by dissolving two subsidiaries, Tianjin Yana Instruments Co., Ltd. and Shandong Tongkang Building Materials Co., Ltd., with completion expected by the end of 2024[49] - The company is actively adjusting its operational and sales strategies in response to market conditions, focusing on inventory reduction to improve cash flow[96] - The company aims to optimize its capital structure and reduce the asset-liability ratio as part of its strategic initiatives to enhance operational efficiency and profitability[96] Research and Development - Total R&D investment was 198.26 million yuan, accounting for 2.75% of operating revenue, with capitalized R&D investment making up 8.48% of total R&D[52] - The company has 4 high-tech enterprises and nearly 150 patents in the pharmaceutical sector, indicating a strong emphasis on innovation[40] - The company is currently preparing for the II phase clinical trial of the H5N1 human avian influenza vaccine[73] - The company will strengthen its R&D management system and enhance team training to mitigate R&D risks and improve efficiency[99] Governance and Compliance - The company held 10 shareholder meetings, 23 board meetings, and 3 supervisory meetings during the reporting period, ensuring compliance with governance regulations[101] - A total of 4 periodic reports and 145 temporary announcements were disclosed, maintaining the timeliness and legality of information disclosure[101] - The company is focused on maintaining compliance with corporate governance standards as evidenced by the proper conduct of shareholder meetings[105] - The independent directors have fulfilled their responsibilities, ensuring that minority shareholders have opportunities to express their opinions and protect their rights[131] Environmental Responsibility - The company invested 27.29 million yuan in environmental protection during the reporting period[138] - A total of 11 subsidiaries were listed as key pollutant discharge units, all meeting emission standards for sulfur dioxide, nitrogen oxides, and particulate matter[138] - The company has implemented advanced pollution control measures, including dust collectors and denitrification devices, achieving full compliance with pollutant discharge standards by 2024[139] - The company is committed to sustainable development and has published its 2024 Social Responsibility Report on the Shanghai Stock Exchange website[147] Shareholder Engagement - The company is planning a shareholder return plan for 2024-2026, reflecting a commitment to shareholder value[114] - The company has initiated a share repurchase plan with a minimum budget of RMB 30 million and a maximum of RMB 50 million, targeting to buy back approximately 1,875,000 to 3,125,000 shares[196] - The share repurchase plan aims to enhance shareholder value and stabilize the stock price[196] Future Outlook - For 2025, the company plans to achieve a revenue of 1,214,165,000 CNY and a net profit of 25,322,000 CNY, indicating a strategic focus on recovery despite market uncertainties[97] - The construction materials industry is expected to benefit from supportive fiscal policies, with infrastructure investment projected to grow by 5% in the region, which may positively impact cement demand[94] - The real estate market is anticipated to stabilize with government measures aimed at promoting housing market recovery, which is crucial for the company's performance[95]

证券代码：600881 证券简称：亚泰集团 公告编号：临 2025-037 号 | 回购方案首次披露日 | 2024/10/12 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 自股东大会审议通过回购股份方案之日起不超过 | | | | | | | | | | 个月（自 年 月 6 30 日止） | 2024 | 10 | 日至 | 2025 | 年 | 4 | 月 29 | | 预计回购金额 | 2,700万元~3,000万元 | | | | | | | | | 回购价格上限 | 2.20元/股 | | | | | | | | | 回购用途 | √减少注册资本 □为维护公司价值及股东权益 | | | | | | | | | 实际回购股数 | 16,762,600股 | | | | | | | | | 实际回购股数占总股本比例 | 0.52% | | | | | | | | | 实际回购金额 | 27,002,347.69元 | | | | | | | | | 实际回购价格区间 | 1.5 ...